Page last updated: 2024-09-05

cgp 54626 and ethosuximide

cgp 54626 has been researched along with ethosuximide in 1 studies

Compound Research Comparison

Studies (cgp 54626)	Trials (cgp 54626)	Recent Studies (post-2010) (cgp 54626)	Studies (ethosuximide)	Trials (ethosuximide)	Recent Studies (post-2010) (ethosuximide)
57	0	16	1,096	37	206

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernasconi, R; Bittiger, H; De Barry, J; Marescaux, C; Mathivet, P	1

Other Studies

1 other study(ies) available for cgp 54626 and ethosuximide

Article	Year
Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist. European journal of pharmacology, 1997, Feb-19, Volume: 321, Issue:1 Topics: Animals; Anticonvulsants; Baclofen; Binding, Competitive; Brain Chemistry; Ethosuximide; GABA Agonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Guanylyl Imidodiphosphate; In Vitro Techniques; Male; Organophosphorus Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptors, GABA-B; Sodium Oxybate; Valproic Acid	1997

Article

Year

Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.

European journal of pharmacology, 1997, Feb-19, Volume: 321, Issue:1

Topics: Animals; Anticonvulsants; Baclofen; Binding, Competitive; Brain Chemistry; Ethosuximide; GABA Agonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Guanylyl Imidodiphosphate; In Vitro Techniques; Male; Organophosphorus Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptors, GABA-B; Sodium Oxybate; Valproic Acid

1997